Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.42 USD | +0.12% | -0.33% | +122.89% |
05-07 | Fusion Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-16 | TD Cowen Downgrades Fusion Pharmaceuticals to Hold | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
- Stock Market
- Equities
- FUSN Stock
- News FUSN PHAR
- Bloom Burton Downgrades Fusion Pharmaceuticals to Hold From Buy, Raises Price Target to $21.50 From $20